Cre-mediated stress affects sirtuin expression levels, peroxisome biogenesis and metabolism, antioxidant and proinflammatory signaling pathways

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Xiao, Yu ^a   Karnati, Srikanth ^a   Qian, Guofeng ^a,c   Nenicu, Anca ^a,d   Fan, Wei ^a   Tchatalbachev, Svetlin ^a   Höland, Anita ^a   Hossain, Hamid ^a   Guillou, Florian ^b   Lüers, Georg H ^a,e   Baumgart Vogt, Eveline ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UMR85 PHYSIOLOGIE DE LA REPRODUCTION ET DES COMPORTEMENTS   (France)

^c ZHEJIANG UNIVERSITY   (China)

^d SAARLAND UNIVERSITY   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ABC TRANSPORTER D1; ABC TRANSPORTER D3; ACETYL COENZYME A ACETYLTRANSFERASE; BINDING PROTEIN; CATALASE; CRE RECOMBINASE; DNA; ENOYL COENZYME A HYDRATASE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; PEROXISOME BIOGENESIS FACTOR 13; PEROXISOME BIOGENESIS FACTOR 14; PEROXISOME BIOGENESIS FACTOR 5; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P53; SIRTUIN; SIRTUIN 1; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DOWN REGULATION; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; GENE INACTIVATION; GERM CELL; HETEROZYGOSITY; HOMOZYGOSITY; LIPID PEROXIDATION; MALE; MICROARRAY ANALYSIS; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PARACRINE SIGNALING; PEROXISOME; PHENOTYPIC VARIATION; PROTEIN EXPRESSION; SERTOLI CELL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; ANTI-MULLERIAN HORMONE; ANTIOXIDANTS; CELLS, CULTURED; CHROMOSOME WALKING; GENOTYPE; INTEGRASES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEROXISOMES; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; SERTOLI CELLS; SIGNAL TRANSDUCTION; SIRTUINS; TESTIS;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 84864039381     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041097     Document Type: Article

References (91)

1. Gu H, Zou YR, Rajewsky K, (1993) Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 73: 1155-1164.
2. Lobe CG, Nagy A, (1998) Conditional genome alteration in mice. Bioessays 20: 200-208.
3. Sternberg N, Hamilton D, (1981) Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. J Mol Biol 150: 467-486.
4. Lewandoski M, (2001) Conditional control of gene expression in the mouse. Nat Rev Genet 2: 743-755.
5. Furuta Y, Behringer RR, (2005) Recent innovations in tissue-specific gene modifications in the mouse. Birth Defects Res C Embryo Today 75: 43-57.
6. Branda CS, Dymecki SM, (2004) Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. Dev Cell 6: 7-28.
7. Loonstra A, Vooijs M, Beverloo HB, Allak BA, van Drunen E, et al. (2001) Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci USA 98: 9209-9214.
8. Pfeifer A, Brandon EP, Kootstra N, Gage FH, Verma IM, (2001) Delivery of the Cre recombinase by a self-deleting lentiviral vector: efficient gene targeting in vivo. Proc Natl Acad Sci USA 98: 11450-11455.
9. Schmidt EE, Taylor DS, Prigge JR, Barnett S, Capecchi MR, (2000) Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids. Proc Natl Acad Sci USA 97: 13702-13707.
10. Buerger A, Rozhitskaya O, Sherwood MC, Dorfman AL, Bisping E, et al. (2006) Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase. J Card Fail 12: 392-398.
11. Lee JY, Ristow M, Lin X, White MF, Magnuson MA, et al. (2006) RIP-Cre revisited, evidence for impairments of pancreatic beta-cell function. J Biol Chem 281: 2649-2653.
12. Baumgart E, Fahimi HD, Steininger H, Grabenbauer M, (2003) A review of morphological techniques for detection of peroxisomal (and mitochondrial) proteins and their corresponding mRNAs during ontogenesis in mice: application to the PEX5-knockout mouse with Zellweger syndrome. Microsc Res Tech 61: 121-138.
13. Baumgart E, (1997) Application of in situ hybridization, cytochemical and immunocytochemical techniques for the investigation of peroxisomes. A review including novel data. Robert Feulgen Prize Lecture 1997. Histochem Cell Biol 108: 185-210.
14. Schrader M, Fahimi HD, (2006) Peroxisomes and oxidative stress. Biochim Biophys Acta 1763: 1755-1766.
15. Masters CJ, Crane DI, (1995) On the role of the peroxisome in ontogeny, ageing and degenerative disease. Mech Ageing Dev 80: 69-83.
16. Karnati S, Baumgart-Vogt E, (2008) Peroxisomes in mouse and human lung: their involvement in pulmonary lipid metabolism. Histochem Cell Biol 130: 719-740.
17. Wanders RJ, Waterham HR, (2006) Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem 75: 295-332.
18. Van Veldhoven PP, (2010) Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism. J Lipid Res 51: 2863-2895.
19. Latruffe N, Cherkaoui Malki M, Nicolas-Frances V, Clemencet MC, Jannin B, et al. (2000) Regulation of the peroxisomal beta-oxidation-dependent pathway by peroxisome proliferator-activated receptor alpha and kinases. Biochem Pharmacol 60: 1027-1032.
20. del Rio LA, Corpas FJ, Sandalio LM, Palma JM, Barroso JB, (2003) Plant peroxisomes, reactive oxygen metabolism and nitric oxide. IUBMB Life 55: 71-81.
21. Girzalsky W, Saffian D, Erdmann R, (2010) Peroxisomal protein translocation. Biochim Biophys Acta 1803: 724-731.
22. Baes M, Gressens P, Baumgart E, Carmeliet P, Casteels M, et al. (1997) A mouse model for Zellweger syndrome. Nat Genet 17: 49-57.
23. Baumgart E, Vanhorebeek I, Grabenbauer M, Borgers M, Declercq PE, et al. (2001) Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Am J Pathol 159: 1477-1494.
24. Goldfischer S, Johnson AB, Essner E, Moore C, Ritch RH, (1973) Peroxisomal abnormalities in metabolic diseases. J Histochem Cytochem 21: 972-977.
25. Gould SJ, Valle D, (2000) Peroxisome biogenesis disorders: genetics and cell biology. Trends Genet 16: 340-345.
26. Baes M, Van Veldhoven PP, (2006) Generalised and conditional inactivation of Pex genes in mice. Biochim Biophys Acta 1763: 1785-1793.
27. Lüers GH, Thiele S, Schad A, Völkl A, Yokota S, et al. (2006) Peroxisomes are present in murine spermatogonia and disappear during the course of spermatogenesis. Histochem Cell Biol 125: 693-703.
28. Nenicu A, Lüers GH, Kovacs W, David M, Zimmer A, et al. (2007) Peroxisomes in human and mouse testis: differential expression of peroxisomal proteins in germ cells and distinct somatic cell types of the testis. Biol Reprod 77: 1060-1072.
29. Dastig S, Nenicu A, Otte DM, Zimmer A, Seitz J, et al. (2011) Germ cells of male mice express genes for peroxisomal metabolic pathways implicated in the regulation of spermatogenesis and the protection against oxidative stress. Histochem Cell Biol 136: 413-425.
30. Lécureuil C, Fontaine I, Crepieux P, Guillou F, (2002) Sertoli and granulosa cell-specific Cre recombinase activity in transgenic mice. Genesis 33: 114-118.
31. Xavier F, Allard S, (2003) Anti-Mullerian hormone, beta-catenin and Mullerian duct regression. Mol Cell Endocrinol 211: 115-121.
32. Siebert PD, Chenchik A, Kellogg DE, Lukyanov KA, Lukyanov SA, (1995) An improved PCR method for walking in uncloned genomic DNA. Nucleic Acids Res 23: 1087-1088.
33. Miller SA, Dykes DD, Polesky HF, (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
34. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
35. Dennis GJ, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
36. Cargnello M, Roux PP, (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75: 50-83.
37. Chen F, (2012) JNK-induced apoptosis, compensatory growth, and cancer stem cells. Cancer Res 72: 379-386.
38. Noon AT, Goodarzi AA, (2011) 53BP1-mediated DNA double strand break repair: insert bad pun here. DNA Repair (Amst) 10: 1071-1076.
39. Baur J, (2010) Sirtuins and Oxidative Stress. Pathways (SABiosciences) 12: 12-13.
40. Schlatt S, Meinhardt A, Nieschlag E, (1997) Paracrine regulation of cellular interactions in the testis: factors in search of a function. Eur J Endocrinol 137: 107-117.
41. Nguyen T, Nioi P, Pickett CB, (2009) The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 284: 13291-13295.
42. Surh YJ, Na HK, (2008) NF-kappaB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals. Genes Nutr 2: 313-317.
43. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, et al. (1995) Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15: 3012-3022.
44. Issemann I, Green S, (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347: 645-650.
45. Issemann I, Green S, (1991) Cloning of novel members of the steroid hormone receptor superfamily. J Steroid Biochem Mol Biol 40: 263-269.
46. Yaqoob P, (2003) Fatty acids as gatekeepers of immune cell regulation. Trends Immunol 24: 639-645.
47. Barrera G, Toaldo C, Pizzimenti S, Cerbone A, Pettazzoni P, et al. (2008) The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products. PPAR Res 2008: 524671.
48. Fahimi HD, Beier K, Lindauer M, Schad A, Zhan J, et al. (1996) Zonal heterogeneity of peroxisome proliferation in rat liver. Ann N Y Acad Sci 804: 341-361.
49. Hashimoto T, Fujita T, Usuda N, Cook W, Qi C, et al. (1999) Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype. J Biol Chem 274: 19228-19236.
50. Jannini EA, Ulisse S, Cecconi S, Cironi L, Colonna R, et al. (1994) Follicle-stimulating hormone-induced phospholipase A2 activity and eicosanoid generation in rat Sertoli cells. Biol Reprod 51: 140-145.
51. Ishikawa T, Morris PL, (2006) A multistep kinase-based sertoli cell autocrine-amplifying loop regulates prostaglandins, their receptors, and cytokines. Endocrinology 147: 1706-1716.
52. Winnall WR, Ali U, O'Bryan MK, Hirst JJ, Whiley PA, et al. (2007) Constitutive expression of prostaglandin-endoperoxide synthase 2 by somatic and spermatogenic cells is responsible for prostaglandin E2 production in the adult rat testis. Biol Reprod 76: 759-768.
53. Konrad L, Lüers GH, Volck-Badouin E, Keilani MM, Laible L, et al. (2006) Analysis of the mRNA expression of the TGF-Beta family in testicular cells and localization of the splice variant TGF-beta2B in testis. Mol Reprod Dev 73: 1211-1220.
54. Konrad L, Keilani MM, Laible L, Nottelmann U, Hofmann R, (2006) Effects of TGF-betas and a specific antagonist on apoptosis of immature rat male germ cells in vitro. Apoptosis 11: 739-748.
55. Li MW, Xia W, Mruk DD, Wang CQ, Yan HH, et al. (2006) Tumor necrosis factor {alpha} reversibly disrupts the blood-testis barrier and impairs Sertoli-germ cell adhesion in the seminiferous epithelium of adult rat testes. J Endocrinol 190: 313-329.
56. Kyronlahti A, Euler R, Bielinska M, Schoeller EL, Moley KH, et al. (2011) GATA4 regulates Sertoli cell function and fertility in adult male mice. Mol Cell Endocrinol 333: 85-95.
57. LaVoie HA, (2003) The role of GATA in mammalian reproduction. Exp Biol Med (Maywood) 228: 1282-1290.
58. Allan CM, Garcia A, Spaliviero J, Zhang FP, Jimenez M, et al. (2004) Complete Sertoli cell proliferation induced by follicle-stimulating hormone (FSH) independently of luteinizing hormone activity: evidence from genetic models of isolated FSH action. Endocrinology 145: 1587-1593.
59. Allan CM, Lim P, Robson M, Spaliviero J, Handelsman DJ, (2009) Transgenic mutant D567G but not wild-type human FSH receptor overexpression provides FSH-independent and promiscuous glycoprotein hormone Sertoli cell signaling. Am J Physiol Endocrinol Metab 296: E1022-1028.
60. Nenicu A, Okun JG, Hartmann MF, Wudy SA, Guillou F, et al. (2009) Molecular pathogenesis of male infertility due to peroxisome dysfunction in Sertoli cells. Biol Reprod 81: Meeting Abstracts 682.
61. Chauvigné F, Verdura S, Mazon MJ, Duncan N, Zanuy S, et al. (2012) Follicle-Stimulating Hormone and Luteinizing Hormone Mediate the Androgenic Pathway in Leydig Cells of an Evolutionary Advanced Teleost. Biol Reprod DOI:10.1095/biolreprod.112.100784. In press.
62. Zarkovic N, Zarkovic K, Schaur RJ, Stolc S, Schlag G, et al. (1999) 4-Hydroxynonenal as a second messenger of free radicals and growth modifying factor. Life Sci 65: 1901-1904.
63. Zarkovic N, (2003) 4-hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med 24: 281-291.
64. Esterbauer H, Schaur RJ, Zollner H, (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81-128.
65. Awasthi YC, Sharma R, Cheng JZ, Yang Y, Sharma A, et al. (2003) Role of 4-hydroxynonenal in stress-mediated apoptosis signaling. Mol Aspects Med 24: 219-230.
66. Chaudhary P, Sharma R, Sharma A, Vatsyayan R, Yadav S, et al. (2010) Mechanisms of 4-Hydroxy-2-nonenal Induced Pro- and Anti-Apoptotic Signaling. Biochemistry 49: 6263-6275.
67. Sauer B, (1992) Identification of cryptic lox sites in the yeast genome by selection for Cre-mediated chromosome translocations that confer multiple drug resistance. J Mol Biol 223: 911-928.
68. Thyagarajan B, Guimaraes MJ, Groth AC, Calos MP, (2000) Mammalian genomes contain active recombinase recognition sites. Gene 244: 47-54.
69. Lombard DB, (2009) Sirtuins at the breaking point: SIRT6 in DNA repair. Aging (Albany NY) 1: 12-16.
70. Kinoshita T, Nagamatsu G, Kosaka T, Takubo K, Hotta A, et al. (2011) Ataxia-telangiectasia mutated (ATM) deficiency decreases reprogramming efficiency and leads to genomic instability in iPS cells. Biochem Biophys Res Commun 407: 321-326.
71. Yuan Z, Zhang X, Sengupta N, Lane WS, Seto E, (2007) SIRT1 regulates the function of the Nijmegen breakage syndrome protein. Mol Cell 27: 149-162.
72. Ozawa Y, Kubota S, Narimatsu T, Yuki K, Koto T, et al. (2010) Retinal aging and sirtuins. Ophthalmic Res 44: 199-203.
73. McCord RA, Michishita E, Hong T, Berber E, Boxer LD, et al. (2009) SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair. Aging (Albany NY) 1: 109-121.
74. Kaidi A, Weinert BT, Choudhary C, Jackson SP, (2010) Human SIRT6 promotes DNA end resection through CtIP deacetylation. Science 329: 1348-1353.
75. Nakagawa T, Guarente L, (2011) Sirtuins at a glance. J Cell Sci 124: 833-838.
76. Mostoslavsky R, Chua KF, Lombard DB, Pang WW, Fischer MR, et al. (2006) Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124: 315-329.
77. Purushotham A, Schug TT, Li X, (2009) SIRT1 performs a balancing act on the tight-rope toward longevity. Aging (Albany NY) 1: 669-673.
78. Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, et al. (2010) Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys 501: 79-90.
79. Han L, Zhou R, Niu J, McNutt MA, Wang P, et al. (2010) SIRT1 is regulated by a PPAR{gamma}-SIRT1 negative feedback loop associated with senescence. Nucleic Acids Res 38: 7458-7471.
80. Luo J, Nikolaev AY, Imai S, Chen D, Su F, et al. (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107: 137-148.
81. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, et al. (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159.
82. Kwon HS, Ott M, (2008) The ups and downs of SIRT1. Trends Biochem Sci 33: 517-525.
83. Kim JE, Chen J, Lou Z, (2008) DBC1 is a negative regulator of SIRT1. Nature 451: 583-586.
84. Zhao W, Kruse JP, Tang Y, Jung SY, Qin J, et al. (2008) Negative regulation of the deacetylase SIRT1 by DBC1. Nature 451: 587-590.
85. Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I, (2005) Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 16: 4623-4635.
86. Sasaki T, Maier B, Bartke A, Scrable H, (2006) Progressive loss of SIRT1 with cell cycle withdrawal. Aging Cell 5: 413-422.
87. Abdelmohsen K, Pullmann R Jr, Lal A, Kim HH, Galban S, et al. (2007) Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell 25: 543-557.
88. Cuadrado A, Nebreda AR, (2010) Mechanisms and functions of p38 MAPK signalling. Biochem J 429: 403-417.
89. Chua KF, Mostoslavsky R, Lombard DB, Pang WW, Saito S, et al. (2005) Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metab 2: 67-76.
90. Naiche LA, Papaioannou VE, (2007) Cre activity causes widespread apoptosis and lethal anemia during embryonic development. Genesis 45: 768-775.
91. Whitsett JA, Perl AK, (2006) Conditional control of gene expression in the respiratory epithelium: A cautionary note. Am J Respir Cell Mol Biol 34: 519-520.